Cargando…
Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile
INTRODUCTION: Saccharomyces boulardii (S. boulardii) has shown clinical beneficial effect in inflammatory bowel diseases recently. However, the underlying mechanisms remain incompletely understood. The aim of present study was to tested whether S. boulardii targets gut microbiota to protect against...
Autores principales: | Gao, Hui, Li, Yinzheng, Xu, Jiqu, Zuo, Xuezhi, Yue, Tiantian, Xu, Huzi, Sun, Jie, Wang, Meng, Ye, Ting, Yu, Yan, Yao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363984/ https://www.ncbi.nlm.nih.gov/pubmed/37492256 http://dx.doi.org/10.3389/fmicb.2023.1204122 |
Ejemplares similares
-
Saccharomyces boulardii Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-κB and Nrf2 Signaling Pathways
por: Gao, Hui, et al.
Publicado: (2021) -
Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
por: Zhou, Huan, et al.
Publicado: (2018) -
Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice
por: Dong, Jin-Pei, et al.
Publicado: (2019) -
Microbiome Engineering Using Probiotic Yeast: Saccharomyces boulardii and the Secreted Human Lysozyme Lead to Changes in the Gut Microbiome and Metabolome of Mice
por: Kim, Jungyeon, et al.
Publicado: (2023) -
Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice
por: Maioli, Tatiani Uceli, et al.
Publicado: (2014)